 It has a simple and adapted regimen, a three-year shelf-ife and a very high compliance rate.ASMQ is produced in Brazil by /Fiocruz and thanks to a South–South technology transfer, it is now also produced by Cipla.The latter was granted "pre-qualified" status by the WHO in 2012 and included on the WHO Model List of Essential Medicines and Essential Medicines List for Children in 2013.